title: Sustained Disease Control with TOMOXIRI Regimen in a Patient with Metastatic Pancreatic Adenocarcinoma.
authors.affiliation: Medical Oncology Department, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, sara.dedosso@eoc.ch.
authors.forename: Sara
authors.initials: S
authors.lastname: De Dosso
authors.forename: Patrizia
authors.initials: P
authors.lastname: Melchiorre
authors.forename: Chiara
authors.initials: C
authors.lastname: Della Badia
authors.forename: Giorgio
authors.initials: G
authors.lastname: Moschovitis
authors.forename: Piercarlo
authors.initials: P
authors.lastname: Saletti
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents
references.citation: Cancer Control. 2004 Jan-Feb;11(1):46-9
references.pmid: 14749623
references.citation: Eur J Cancer. 2006 Jan;42(2):193-9
references.pmid: 16330204
references.citation: Lancet. 2002 May 4;359(9317):1555-63
references.pmid: 12047964
references.citation: Cancer. 1993 Jan 15;71(2):493-509
references.pmid: 8422644
references.citation: Eur J Cancer. 2013 Jul;49(10):2303-10
references.pmid: 23583220
references.citation: Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):1-5
references.pmid: 16529545
references.citation: N Engl J Med. 2011 May 12;364(19):1817-25
references.pmid: 21561347
references.citation: Ann Oncol. 2003 Apr;14(4):574-9
references.pmid: 12649104
references.citation: Br J Cancer. 2006 Mar 27;94(6):785-91
references.pmid: 16508631
references.citation: N Engl J Med. 2013 Oct 31;369(18):1691-703
references.pmid: 24131140
references.citation: Cancer Res. 1993 Jul 1;53(13):3028-33
references.pmid: 8391384
references.citation: Oncology. 2004;67(5-6):338-43
references.pmid: 15713988
references.citation: Clin Cancer Res. 1998 May;4(5):1323-30
references.pmid: 9607593
references.citation: Br J Cancer. 2000 Jul;83(2):146-52
references.pmid: 10901362
references.citation: J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):281-4
references.pmid: 19561527
references.citation: Oncology. 2005;68(4-6):299-305
references.pmid: 16020956
references.citation: Br J Cancer. 2003 Apr 22;88(8):1180-4
references.pmid: 12698181
references.citation: J Cancer Res Clin Oncol. 2008 Jan;134(1):75-82
references.pmid: 17636329
references.citation: Eur Heart J. 1991 Mar;12 (3):468-70
references.pmid: 2040332
references.citation: Expert Opin Drug Saf. 2009 Mar;8(2):191-202
references.pmid: 19309247
references.citation: J Clin Oncol. 1997 Jun;15(6):2403-13
references.pmid: 9196156
references.citation: Ann Oncol. 2014 Jan;25(1):117-21
references.pmid: 24299960